IndraLab

Statements


| 3

sparser
"Vasoformation is identified, which distinguishes it from WWTR1CAM1 fusion-associated tumor."

sparser
"Epithelioid hemangioendothelioma with YAP1–TFE3 fusion has a higher chance of multifocal disease and metastasis as compared to tumors with WWTR1CAM1 fusion; however, the former has a 5-year progression-free survival range of 85–90% as compared to the latter [ xref , xref ]."

sparser
"One shows WWTR1CAM1 fusion, is more common, and is seen in 90% of patients [ xref , xref , xref ]."